Jacobs Levy Equity Management, Inc Homology Medicines, Inc. Transaction History

Jacobs Levy Equity Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.91 - $1.69 $115,731 - $214,930	127,178 Added 178.46%	198,444 $204,000
Q4 2022 Feb 14, 2023	SELL	$1.09 - $2.04 $10,692 - $20,012	-9,810 Reduced 12.1%	71,266 $89,000
Q3 2022 Nov 15, 2022	SELL	$1.55 - $3.01 $4,992 - $9,695	-3,221 Reduced 3.82%	81,076 $131,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $546,745 - $1.23 Million	-393,342 Reduced 82.35%	84,297 $166,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $928,876 - $1.49 Million	-357,260 Reduced 42.79%	477,639 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $137,235 - $293,321	-37,702 Reduced 4.32%	834,899 $3.04 Million
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $845,234 - $1.22 Million	-140,638 Reduced 13.88%	872,601 $6.87 Million
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $2.46 Million - $3.94 Million	409,074 Added 67.71%	1,013,239 $7.37 Million
Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $1.04 Million - $1.68 Million	113,289 Added 23.08%	604,165 $5.69 Million
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $555,171 - $827,156	62,239 Added 14.52%	490,876 $5.54 Million
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $1.17 Million - $1.96 Million	118,159 Added 38.06%	428,637 $4.59 Million
Q2 2020 Aug 17, 2020	BUY	$12.07 - $19.34 $3.75 Million - $6 Million	310,478 New	310,478 $4.72 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.